Reimbursement and Coding for SBIRT
Reimbursement and Coding for SBIRT – Presenter: Presenter: Joseph Hurley is president of Primary Care National and the Executive Director of MediCenter Health Systems in Kenai, AK. Mr.Hurley’s p…
BioDelivery Sciences to Present at the 8th Annual JMP Securities Healthcare …
Additionally, Dr. Sirgo will provide an update on the progress made by BDSI and its commercial partner, Endo Health Solutions, with the ongoing Phase 3 clinical program for BEMA Buprenorphine for the treatment of chronic pain, along with BDSI's recent …
Read more on NCTechNews (press release)
FDA approves Orexo's Zubsolv as opioid dependence maintenance therapy
Indicated for use as part of a complete treatment plan, including counseling and psychosocial support, the once-daily, sublingual tablet is an advanced formulation of buprenorphine and naloxone. Expected to be launched in September 2013 by Orexo US and …
Read more on Pharmaceutical Business Review
Editorial: Conscietious Objection; A Doctor Battles Regulators
Moreover, Schorsch's treatment often involves buprenorphine, a synthetic opioid that, unlike methadone, blocks the effects of other opiates — precluding the possibility that patients might use it to enhance other substances. Schorsch regards …
Read more on Valley News
Related Buprenorphine Treatment Information…